Treatment of Leptomeningeal Metastases: New Hammer, the Same Nail

Affiliations

¹ Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Cancer Center, W.G. (Bill) Hefner Veteran Administration Medical Center, Salisbury, North Carolina; Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina. Electronic address: jruiz@wakehealth.edu.
² Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
³ Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina; Department of Neurology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.

Free article

Editorial

Jimmy Ruiz et al. J Thorac Oncol. 2021 Aug.

Free article

. 2021 Aug;16(8):1244-1246.

doi: 10.1016/j.jtho.2021.06.009.

¹ Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Cancer Center, W.G. (Bill) Hefner Veteran Administration Medical Center, Salisbury, North Carolina; Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina. Electronic address: jruiz@wakehealth.edu.
² Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
³ Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina; Department of Neurology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.

No abstract available

Comment on

Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC-a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615).
Fan C, Zhao Q, Li L, Shen W, Du Y, Teng C, Gao F, Song X, Jiang Q, Huang D, Jin Y, Lv Y, Wei L, Shi T, Zhao X, Gao N, Jiang Z, Xin T. Fan C, et al. J Thorac Oncol. 2021 Aug;16(8):1359-1368. doi: 10.1016/j.jtho.2021.04.018. Epub 2021 May 11. J Thorac Oncol. 2021. PMID: 33989780 Clinical Trial.